nivolumab,ipilimumab
bms
['scandium 2', 'scandium']
 including pemdac, scandium 2 (also presented at asco) and haitils. and none of that would have happened without the scandium trial. importantly, whilst os was not statistically improved, pfs shows that nothing can push back mum better than perfusion. we need to harness this ft! 
Professor of something but not of everything